Sanofi currently has two COVID-19 vaccine candidates in clinical trials, which are likely to be key products from this plant, if they pass regulatory review. This plant will leverage Singapore's capabilities in advanced manufacturing...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)